View Future GrowthLocus Cell 過去の業績過去 基準チェック /06Locus Cellの収益は年間平均-39.1%の割合で減少していますが、 Life Sciences業界の収益は年間 増加しています。収益は年間6.3% 83.9%割合で 増加しています。主要情報-39.08%収益成長率6.31%EPS成長率Life Sciences 業界の成長5.47%収益成長率83.87%株主資本利益率-11.71%ネット・マージン-1,425.20%前回の決算情報31 Dec 2025最近の業績更新Reported Earnings • Apr 05Full year 2025 earnings released: NT$0.91 loss per share (vs NT$0.56 loss in FY 2024)Full year 2025 results: NT$0.91 loss per share (further deteriorated from NT$0.56 loss in FY 2024). Net loss: NT$181.5m (loss widened 61% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.Reported Earnings • Apr 16Full year 2023 earnings released: NT$0.48 loss per share (vs NT$0.27 loss in FY 2022)Full year 2023 results: NT$0.48 loss per share (further deteriorated from NT$0.27 loss in FY 2022). Net loss: NT$96.9m (loss widened 81% from FY 2022).すべての更新を表示Recent updatesNew Risk • Apr 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$601m free cash flow). Earnings have declined by 39% per year over the past 5 years. Revenue is less than US$1m (NT$13m revenue, or US$400k). Minor Risk Share price has been volatile over the past 3 months (9.1% average weekly change).Reported Earnings • Apr 05Full year 2025 earnings released: NT$0.91 loss per share (vs NT$0.56 loss in FY 2024)Full year 2025 results: NT$0.91 loss per share (further deteriorated from NT$0.56 loss in FY 2024). Net loss: NT$181.5m (loss widened 61% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.お知らせ • Mar 10Locus Cell Co., Ltd., Annual General Meeting, Jun 25, 2026Locus Cell Co., Ltd., Annual General Meeting, Jun 25, 2026. Location: 1 floor no,152, sec.1 ta t`ung rd., sijhih district, new taipei city TaiwanNew Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$572m free cash flow). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (NT$5.2m revenue, or US$165k). Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).New Risk • Sep 18New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -NT$572m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$572m free cash flow). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (NT$5.2m revenue, or US$172k). Minor Risk Share price has been volatile over the past 3 months (7.4% average weekly change).New Risk • Aug 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 43% per year over the past 5 years. Revenue is less than US$1m (NT$2.4m revenue, or US$77k). Minor Risk Share price has been volatile over the past 3 months (6.2% average weekly change).New Risk • Mar 28New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 47% per year over the past 5 years. Revenue is less than US$1m (NT$1.0m revenue, or US$31k). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (6.0% average weekly change).お知らせ • Mar 10Locus Cell Co., Ltd., Annual General Meeting, Jun 20, 2025Locus Cell Co., Ltd., Annual General Meeting, Jun 20, 2025. Location: 1 floor no,152, sec.1 ta t`ung rd., sijhih district, new taipei city TaiwanNew Risk • Mar 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 47% per year over the past 5 years. Revenue is less than US$1m (NT$1.0m revenue, or US$32k). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).お知らせ • Nov 16Locus Cell Co., Ltd. Announces Committee AppointmentsOn November 15, 2024, Locus Cell Co., Ltd. announced two additional independent directors to its audit committee. Name of the new position holder: Independent director, Bao-Huei Huang, Director of Tatung Company; Independent director, Chih-Cheng Wang, Professor, College of Law, Chinese Culture University. Reason for the change: By-election of independent directors. Effective date of the new member: November 15, 2024.お知らせ • Sep 12Locus Cell Co., Ltd. Announces Resignation of Kuan-Ling Lai as Natural-Person DirectorLocus Cell Co., Ltd. announced resignation of Kuan-Ling Lai as natural-person director. Resume of the previous position holder: Special Assistant to the Deputy Chairman, Tatung Company. Reason for the change:Busy on work. Effective date of resignation is September 10, 2024.お知らせ • Aug 30Locus Cell Co., Ltd. Announces Resignation of Fang-Chen Kao as Director, Effective August 30, 2024Locus Cell Co., Ltd. announced that the resignation of natural-person director of the company the company's 2024 regular shareholders meeting. Title and name of the previous position holder: Director, Fang-Chen Kao. Resume of the previous position holder: Chairman of Yu Meng Biomedical Co., Ltd. The company received the resignation letter on August 29, 2024, and the effective date of resignation is August 30, 2024.お知らせ • Jun 27Locus Cell Co., Ltd. Appoints Kun-Ying, Tsai as Chief Operating Officer, Effective July 15, 2024Locus Cell Co., Ltd. announced the board of directors has resolved to appoint a chief operating officer. Name, title, and resume of the new position holder: Mr. Kun-Ying, Tsai. Type of change: New replacement. Effective date: July 15, 2024.お知らせ • May 25+ 1 more updateLocus Cell Co., Ltd. Announces Board ChangesLocus Cell Co., Ltd. announced the election of chairman of the board of directors of the company. Position: Chairperson. Name of the previous position holder: Hong-Nerng Ho. Resume of the previous position holder: Adviser of Taipei Medical University. Name of the new position holder: Jiunn-Rong Chiou. Resume of the new position holder: Professor of Economics, National Central University. Circumstances of change: Term expired. Reason for the change: Comprehensive re-election of directors (including independent directors). Effective date of the new appointment: May 24, 2024.Reported Earnings • Apr 16Full year 2023 earnings released: NT$0.48 loss per share (vs NT$0.27 loss in FY 2022)Full year 2023 results: NT$0.48 loss per share (further deteriorated from NT$0.27 loss in FY 2022). Net loss: NT$96.9m (loss widened 81% from FY 2022).New Risk • Mar 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 100% over the past year. Revenue is less than US$1m. Minor Risk Share price has been volatile over the past 3 months (6.4% average weekly change).お知らせ • Mar 08Locus Cell Co., Ltd., Annual General Meeting, May 24, 2024Locus Cell Co., Ltd., Annual General Meeting, May 24, 2024. Location: 1F No. 152 Sec. 1 Datong Rd. Xizhi District, New Taipei City (Yi Yuan Garden, Fushin Hotel) New Taipei City Taiwan Agenda: To consider 2023 Business Report; Audit Committees Review Report on the 2023 Accounting Final Statements; Report on implementation of the Companys Sound Business Plan; Report on revision of certain articles in the Company; Ratification of the Business Report and Financial Statements for 2023; Ratification of the Loss Compensation Plan for 2023; and to discuss other matters.お知らせ • Dec 29Locus Cell Co., Ltd. Approves Establishment of Information Security Committee and Appoints First Committee MembersLocus Cell Co., Ltd. approved the establishment of the Information Security Committee and appointed first committee members. Name of the new position holder: Wen-Yuan Lin, Kuo-Bin Lin, Chun-Nong Cheng, Shih-Chia Lin, Yeong-Sung Lin. Resume of the new position holder: Wen-Yuan Lin, Independent Director of Locus Cell; Kuo-Bin Lin, Independent Director of Locus Cell; Chun-Nong Cheng, Independent Director of Locus Cell; Shih-Chia Lin, Director and Chief Executive Officer of Locus Cell; Yeong-Sung Lin, Information Security Consultant of Locus Cell. Effective date of the new member is December 27, 2023.収支内訳Locus Cell の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史TPEX:6891 収益、費用、利益 ( )TWD Millions日付収益収益G+A経費研究開発費31 Dec 2513-182928830 Sep 259-173908630 Jun 255-164888431 Mar 254-148888231 Dec 242-113837830 Sep 242-128837530 Jun 241-109847131 Mar 241-91806531 Dec 230-97796130 Sep 230-77765630 Jun 231-72684931 Mar 231-66634131 Dec 221-53613230 Sep 221-44572130 Jun 220-54571331 Mar 220-4444631 Dec 210-35322質の高い収益: 6891は現在利益が出ていません。利益率の向上: 6891は現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 6891は利益が出ておらず、過去 5 年間で損失は年間39.1%の割合で増加しています。成長の加速: 6891の過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: 6891は利益が出ていないため、過去 1 年間の収益成長をLife Sciences業界 ( 19.1% ) と比較することは困難です。株主資本利益率高いROE: 6891は現在利益が出ていないため、自己資本利益率 ( -11.71% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/30 13:54終値2026/07/30 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Locus Cell Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Apr 05Full year 2025 earnings released: NT$0.91 loss per share (vs NT$0.56 loss in FY 2024)Full year 2025 results: NT$0.91 loss per share (further deteriorated from NT$0.56 loss in FY 2024). Net loss: NT$181.5m (loss widened 61% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.
Reported Earnings • Apr 16Full year 2023 earnings released: NT$0.48 loss per share (vs NT$0.27 loss in FY 2022)Full year 2023 results: NT$0.48 loss per share (further deteriorated from NT$0.27 loss in FY 2022). Net loss: NT$96.9m (loss widened 81% from FY 2022).
New Risk • Apr 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$601m free cash flow). Earnings have declined by 39% per year over the past 5 years. Revenue is less than US$1m (NT$13m revenue, or US$400k). Minor Risk Share price has been volatile over the past 3 months (9.1% average weekly change).
Reported Earnings • Apr 05Full year 2025 earnings released: NT$0.91 loss per share (vs NT$0.56 loss in FY 2024)Full year 2025 results: NT$0.91 loss per share (further deteriorated from NT$0.56 loss in FY 2024). Net loss: NT$181.5m (loss widened 61% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.
お知らせ • Mar 10Locus Cell Co., Ltd., Annual General Meeting, Jun 25, 2026Locus Cell Co., Ltd., Annual General Meeting, Jun 25, 2026. Location: 1 floor no,152, sec.1 ta t`ung rd., sijhih district, new taipei city Taiwan
New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$572m free cash flow). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (NT$5.2m revenue, or US$165k). Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).
New Risk • Sep 18New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -NT$572m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$572m free cash flow). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (NT$5.2m revenue, or US$172k). Minor Risk Share price has been volatile over the past 3 months (7.4% average weekly change).
New Risk • Aug 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 43% per year over the past 5 years. Revenue is less than US$1m (NT$2.4m revenue, or US$77k). Minor Risk Share price has been volatile over the past 3 months (6.2% average weekly change).
New Risk • Mar 28New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 47% per year over the past 5 years. Revenue is less than US$1m (NT$1.0m revenue, or US$31k). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (6.0% average weekly change).
お知らせ • Mar 10Locus Cell Co., Ltd., Annual General Meeting, Jun 20, 2025Locus Cell Co., Ltd., Annual General Meeting, Jun 20, 2025. Location: 1 floor no,152, sec.1 ta t`ung rd., sijhih district, new taipei city Taiwan
New Risk • Mar 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 47% per year over the past 5 years. Revenue is less than US$1m (NT$1.0m revenue, or US$32k). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).
お知らせ • Nov 16Locus Cell Co., Ltd. Announces Committee AppointmentsOn November 15, 2024, Locus Cell Co., Ltd. announced two additional independent directors to its audit committee. Name of the new position holder: Independent director, Bao-Huei Huang, Director of Tatung Company; Independent director, Chih-Cheng Wang, Professor, College of Law, Chinese Culture University. Reason for the change: By-election of independent directors. Effective date of the new member: November 15, 2024.
お知らせ • Sep 12Locus Cell Co., Ltd. Announces Resignation of Kuan-Ling Lai as Natural-Person DirectorLocus Cell Co., Ltd. announced resignation of Kuan-Ling Lai as natural-person director. Resume of the previous position holder: Special Assistant to the Deputy Chairman, Tatung Company. Reason for the change:Busy on work. Effective date of resignation is September 10, 2024.
お知らせ • Aug 30Locus Cell Co., Ltd. Announces Resignation of Fang-Chen Kao as Director, Effective August 30, 2024Locus Cell Co., Ltd. announced that the resignation of natural-person director of the company the company's 2024 regular shareholders meeting. Title and name of the previous position holder: Director, Fang-Chen Kao. Resume of the previous position holder: Chairman of Yu Meng Biomedical Co., Ltd. The company received the resignation letter on August 29, 2024, and the effective date of resignation is August 30, 2024.
お知らせ • Jun 27Locus Cell Co., Ltd. Appoints Kun-Ying, Tsai as Chief Operating Officer, Effective July 15, 2024Locus Cell Co., Ltd. announced the board of directors has resolved to appoint a chief operating officer. Name, title, and resume of the new position holder: Mr. Kun-Ying, Tsai. Type of change: New replacement. Effective date: July 15, 2024.
お知らせ • May 25+ 1 more updateLocus Cell Co., Ltd. Announces Board ChangesLocus Cell Co., Ltd. announced the election of chairman of the board of directors of the company. Position: Chairperson. Name of the previous position holder: Hong-Nerng Ho. Resume of the previous position holder: Adviser of Taipei Medical University. Name of the new position holder: Jiunn-Rong Chiou. Resume of the new position holder: Professor of Economics, National Central University. Circumstances of change: Term expired. Reason for the change: Comprehensive re-election of directors (including independent directors). Effective date of the new appointment: May 24, 2024.
Reported Earnings • Apr 16Full year 2023 earnings released: NT$0.48 loss per share (vs NT$0.27 loss in FY 2022)Full year 2023 results: NT$0.48 loss per share (further deteriorated from NT$0.27 loss in FY 2022). Net loss: NT$96.9m (loss widened 81% from FY 2022).
New Risk • Mar 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 100% over the past year. Revenue is less than US$1m. Minor Risk Share price has been volatile over the past 3 months (6.4% average weekly change).
お知らせ • Mar 08Locus Cell Co., Ltd., Annual General Meeting, May 24, 2024Locus Cell Co., Ltd., Annual General Meeting, May 24, 2024. Location: 1F No. 152 Sec. 1 Datong Rd. Xizhi District, New Taipei City (Yi Yuan Garden, Fushin Hotel) New Taipei City Taiwan Agenda: To consider 2023 Business Report; Audit Committees Review Report on the 2023 Accounting Final Statements; Report on implementation of the Companys Sound Business Plan; Report on revision of certain articles in the Company; Ratification of the Business Report and Financial Statements for 2023; Ratification of the Loss Compensation Plan for 2023; and to discuss other matters.
お知らせ • Dec 29Locus Cell Co., Ltd. Approves Establishment of Information Security Committee and Appoints First Committee MembersLocus Cell Co., Ltd. approved the establishment of the Information Security Committee and appointed first committee members. Name of the new position holder: Wen-Yuan Lin, Kuo-Bin Lin, Chun-Nong Cheng, Shih-Chia Lin, Yeong-Sung Lin. Resume of the new position holder: Wen-Yuan Lin, Independent Director of Locus Cell; Kuo-Bin Lin, Independent Director of Locus Cell; Chun-Nong Cheng, Independent Director of Locus Cell; Shih-Chia Lin, Director and Chief Executive Officer of Locus Cell; Yeong-Sung Lin, Information Security Consultant of Locus Cell. Effective date of the new member is December 27, 2023.